Sergio Pupkin
Vermögen: 471 651 $ am 31.05.2026
Vermögen: 471 651 $ am 31.05.2026
Sergio A. Pupkin is currently an Independent Director at UniFirst Corp.
since 2022.
He is also a Director at Sterilex LLC and Circularix LLC.
Formerly, Mr. Pupkin was Chief Growth & Strategic Officer and Vice President at Sealed Air Corp.
from 2016 to 2023.
Additionally, Mr. Pupkin worked as Global VP-Marketing & Business Development at Diversey, Inc. Mr. Pupkin completed graduate studies at Universidad de Buenos Aires.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
UNIFIRST CORPORATION 0.01% | 16.12.2025 | 1’777 ( 0.01% ) | 471 651 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| UNIFIRST CORPORATION | Direktor/Vorstandsmitglied | 24.10.2022 |
Sterilex LLC
Sterilex LLC BiotechnologyHealth Technology Develops solutions for microbial control | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| SEALED AIR CORPORATION | Corporate Officer/Principal | 31.12.2023 |
Diversey, Inc.
Diversey, Inc. Household/Personal CareConsumer Non-Durables Manufactures cleaning solutions | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Sealed Air Corp.
Sealed Air Corp. Containers/PackagingProcess Industries Manufactures protective packaging products | Process Industries |
UniFirst Corp.
UniFirst Corp. Other Consumer ServicesConsumer Services Provides workplace uniforms, protective clothing, and facility services products | Consumer Services |
Diversey, Inc.
Diversey, Inc. Household/Personal CareConsumer Non-Durables Manufactures cleaning solutions | Consumer Non-Durables |
Universidad de Buenos Aires
Universidad de Buenos Aires Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sterilex LLC
Sterilex LLC BiotechnologyHealth Technology Develops solutions for microbial control | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen